Metabolomics reveals the perturbations in the metabolome of Caenorhabditis elegans exposed to titanium dioxide nanoparticles

Nanotoxicology

Volumn 9, Issue 8, 2015, Pages 994-1004

  Ratnasekhar, Ch ^a,b   Sonane, Madhavi ^a,c   Satish, Aruna ^a,b   Mudiam, Mohana Krishna Reddy ^a,b  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^c UNIVERSITY OF LUCKNOW   (India)

Author keywords

C. elegans; GC MS; metabolomics; nanoparticles toxicity; TiO2 nanoparticles

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; CARBOHYDRATE; CARBOXYLIC ACID; GLYOXYLIC ACID; TITANIUM DIOXIDE NANOPARTICLE; TRICARBOXYLIC ACID; NANOPARTICLE; TITANIUM; TITANIUM DIOXIDE;

ARACHIDONIC ACID METABOLISM; ARTICLE; CAENORHABDITIS ELEGANS; CITRIC ACID CYCLE; CONTROLLED STUDY; LETHAL CONCENTRATION; MASS FRAGMENTOGRAPHY; METABOLOME; METABOLOMICS; NONHUMAN; OXIDATIVE STRESS; PATTERN RECOGNITION; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; REPRODUCTION; SIGNAL TRANSDUCTION;

ANIMALS; CAENORHABDITIS ELEGANS; METABOLOME; METABOLOMICS; NANOPARTICLES; REPRODUCTION; SIGNAL TRANSDUCTION; TITANIUM;

EID: 84942981042     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2014.993345     Document Type: Article

References (67)

1. Behm CA. 2002. Metabolism. In: Lee DL, ed. Biology of Nematode. New York: Taylor and Francis Inc.
2. Berridge MJ. 1993. Inositol triphosphate and calcium signalling. Nature 361:315-25.
3. Brayner R. 2008. The toxicological impact of nanoparticles. Nanotoday 3: 48-55.
4. Broadhurst DI, Kell DB. 2006. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2: 171-96.
5. Bruna E, Petit E, Beljean LM, Huynh S. Nouvelot A. 1989. Specific susceptibility of docosahexaenoic acid and eicosapentaenoic acid to peroxidation in aqueous solution. Lipids 24:970-5.
6. Bujak R, García-Álvarez A, Rupérez FJ, Nuño-Ayala M, García A, Ruiz-Cabello J, et al. 2014. Metabolomics reveals metabolite changes in acute pulmonary metabolism. J Protome Res 13:805-16.
7. Bundy JG, Davey MP, Viant MR. 2009. Environmental metabolomics: a critical review and future perspectives. Metabolomics 5:3-21.
8. Butler JA, Mushur RJ, Bokov AF, Hakala KW, Weintraub ST, Rea SL. 12. Profiling of anaerobic response of C. elegans using GC-MS. PLoS One 7:e46140.
9. 2. 2011. Department of Health and Human Services, Centres for Disease Control and Prevention, National Institute for Occupational Safety and Health (NIOHS). 160:1-119.
10. Dettemer K, Aronov PA, Hammock BD. 2007. Mass spectrometry-based metabolomics. Mass Spectrum Rev 26:51-78.
11. Donkin SG, Williams PL. 1995. Influence of developmental stage, salts and food presence on various end points using Caenorhabditis elegans for aquatic toxicity testing. Environ Toxicol Chem 14:2139-47.
12. Downes CP, Macphee CH. 1990. Myo-inositol metabolites as cellular signals. Eur J Biochem 193:1-18.
13. Edwards CB, Copes N, Brito AG, Canfield J, Bradshaw PC. 2013. Malate and fumarate extend lifespan in Caenorhabditis elegans. PLoS One 8: e58345.
14. Firnhaber C, Hammarlund M. 2013. Neuron-specific feeding RNAi in C. elegans and its use in a screen for essential genes required for GABA neuron function. PLoS Genet 9:e1003921.
15. Föll RL, Pleyer A, Lewandovski GJ, Wermter C, Hegemann V, Paul RJ. 1999. Anaerobiosis in the nematode Caenorhabditis elegans. Comp Biochem Physiol B: Biochem Mol Biol 124:269-80.
16. Geier FM, Want EJ, Leroi AM, Bundy JG. 2011. Cross-platform comparison of Caenorhabditis elegans tissue extraction strategies for comprehensive metabolome coverage. Anal Chem 83:3730-6.
17. Gems D, Doonan R. 2008. The nematode Caenorhabditis elegans: oxidative stress and aging in the nematode Caenorhabditis elegans. In: Miwa S, Beckman KB, Muller FL, eds. Oxidative Stress in Aging: From Model Systems to Human Diseases. Totowa, NJ: Humana Press, 81-108.
18. Gordon AT, Lutz GE, Boninger ML, Cooper RA. 2007. Introduction to nanotechnology: potential applications in physical medicine and rehabilitation. Am J Phys Med Rehabil 86:225-41.
19. Greer EL, Maures TJ, Hauswirth AG, Green EM, Leeman DS, Maro GS, et al. 2010. Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans. Nature 466: 383-7.
20. Hamilton B, Dong Y, Shindo M, LiuW, Odell I, Ruvkun G, Lee SS. 2005. A systematic RNAi screen for longevity genes in C. elegans. Genes Dev 19:1544-55.
21. Hayauchi YA. 2005. Precise colour determination method for tablets-an application of instrumental colour measurement in the pharmaceutical development. Pharmeur Sci Notes 2005:21-6.
22. Hext PM, Tomenson JA, Thompson P. 2005. Titanium dioxide: inhalation toxicology and epidemiology. Ann Occup Hyg 49:461-72.
23. Horton HR, Moran LA, Scrimgeour KG, Perry MD, Rawn JD. 2006. Principles of Biochemistry. 4th ed. Upper Saddle river, NJ: Pearson Prentice Hall.
24. Hu ZP, Browne ER, Liu T, Angel TE, Ho PC, Chan EC. 2012. Metabolomic profiling of TASTPM transgenic Alzheimer's disease mouse model. J Proteome Res 11:5903-13.
25. Hughes SL, Bundy JG, Want EJ, Kille P, Stuürzenbaum SR. 2009. The metabolomic responses of Caenorhabditis elegans to cadmium are largely independent of metallothionein status, but dominated by changes in cystathionine and phytochelatins. J Proteome Res 8: 3512-19.
26. IARC. 2010. 93. IARC monographs on the evaluation of carcinogenic risks to humans: carbon black, titanium dioxide, and talc. Lyon, France: World Health Organization, International Agency for Research on Cancer. [http://monographs.iarc.fr/ENG/Monographs/vol93/index.php].
27. Izrayelit Y, Robinette SL, Bose N, von Reuss SH, Schroeder FC. 2013. 2D NMR-based metabolomics uncovers interactions between conserved biochemical pathways in the model organism Caenorhabditis elegans. ACS Chem Biol 8:314-19.
28. Jin Y, Jorgensen E, Hartwieg E, Horvitz HR. 1999. The Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase and is required for synaptic transmission but not synaptic development. J Neurosci 19:539-48.
29. Jones OA, Swain SC, Svendsen C, Griffin JL, Sturzenbaum SR, Spurgeon DJ. 2012. Potential new method of mixture effects testing using metabolomics and Caenorhabditis elegans. J Proteome Res 11: 1446-53.
30. Khare P, Sonane M, Nagar Y, Moin N, Ali S, Gupta KC, et al. 2014. Size dependent toxicity of zinc oxide nanoparticles in soil nematode Caenorhabditis elegans. Nanotoxicology. doi:10.3109/17435390. 2014.940403.
31. 2 and ZnO nanoparticles in soil nematode, Caenorhabditis elegans. J Biomed Nanotechnol 7:116-17.
32. Kimata T, Tanizawa Y, Can Y, Ikeda S, Kuhara A, Mori I. 2012. Synaptic polarity depends on phosphatidylinositol signaling regulated by myoinositol monophosphatase in Caenorhabditis elegans. Genetics 191: 509-21.
33. Koek MM, Jellema RH, Greef JVD, Tas AC, Hankemeier T. 2011. Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives. Metabolomics 7:307-28.
34. Koek MM, Muilwijk B, Vanderwerf MJ, Hankemeier T. 2006. Microbial metabolomics with gas chromatography/mass spectrometry. Anal Chem 78:1272-81.
35. Kuehnbaum NL, Britz-McKibbin P. 2013. New advances in separation science for metabolomics: resolving chemical diversity in a postgenomic era. Chem Rev 113:2437-68.
36. Lei Z, Huhman D, Sumner LW. 2011. Mass spectrometry strategies in metabolomics. J Biol Chem 286:25435-42.
37. Lesa GM, Palfreyman M, Hall DH, Clandinin MT, Rudolph C, Jorgensen EM, Schiavo G. 2003. Long chain polyunsaturated fatty acids are required for efficient neurotransmission in C. elegans. J Cell Sci 116: 4965-75.
38. Leung MC, Williams PL, Benedetto A, Au C, Helmcke KJ, Aschner M, et al. 2008. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci 106:5-28.
39. Lindon JC, Nicholson JK, Holmes E, Everett JR. 2006. Metabonomics: metabolic process studied by NMR spectroscopy of biofluids. Concepts Magn Reson 12:289-320.
40. Lokesh BR, Mathur SN, Spector AA. 1981. Effect of fatty acid saturation on NADPH-dependent lipid peroxidation in rat liver microsomes. J Lipid Res 22:905-15.
41. Lundstedt T, Seifert E, Abramo L, Thelin B, Nystrom A, Pattersen J, et al. 1998. Experimental design and optimization. Chemometr Intell Lab 42:3-40.
42. Maurer-Jones MA, Gunsolus IL, Murphy CJ, Haynes CL. 2013. Toxicity of engineered nanoparticles in the environment. Anal Chem 85: 3036-49.
43. 2 nanoparticles induce dysfunction and activation of human endothelial cells. Chem Res Toxicol 25:920-30.
44. Mudiam MKR, Ratnasekhar C, Saxena PN. 2013. Gas chromatography mass spectrometry based metabolomic approach for optimization and toxicity evaluation of earthworm sub-lethal responses to carbofuran. PLoS One 8:e81077.
45. Pun PB, Murphy MP. 2012. Pathological significance of mitochondrial glycation. Int J Cell Biol 2012:1-13.
46. Reddy LH, Arias JL, Nicolas J, Couvreur P. 2012. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 112: 5818-78.
47. Rubingh CM, Bijlsma S, Derks EPPA, Bobeldijk I, Verheij ER, Kochhar S, et al. 2006. Assessing the performance of statistical validation tools for megavariate metabolomics data. Metabolomics 2: 53-61.
48. Ryan D, Robards K. 2006. Metabolomics: the greatest omics of them all? Anal Chem 78:7954-8.
49. Saji VS, Choe HC, Kelvin Yeung WK. 2010. Nanotechnology in biomedical applications: a review. Int J Nano Biomater 3:119-39.
50. Salthammer T, Fuhrmann F. 2007. Photocatalytic surface reactions on indoor wall paint. Environ Sci Technol 41:6573-8.
51. Shi H, Magaye R, Castranova V, Zhao J. 2013. Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol 10:1-33.
52. Taylor NS, Weber RJM, White TA, Viant MR. 2010. Discriminating between different acute chemical toxicities via changes in the daphnid metabolome. Toxicol Sci 118:307-17.
53. Tissenbaum HA, Ruvkun G. 1998. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 148:703-17.
54. 2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes. Cell Death Dis 4: e549.
55. USFDA, 2012: Code of Federal Regulations Title 21. Part 73-Listing of color additives exempt from certification.
56. Varmuza K, Filzmoser P. 2009. Introduction to Multivariate Statistical Analysis in Chemometrics. Boca Raton, FL: CRC Press.
57. Wan R, Mo Y, Feng L, Chien S, Tollerud DJ, Zhang Q. 2012. DNA damage caused by metal nanoparticles: involvement of oxidative stress and activation of ATM. Chem Res Toxicol 25:1402-11.
58. Watts JL, Browse J. 2002. Genetic dissection of polyunsaturated fatty acid synthesis in Caenorhabditis elegans. PNAS 99:5854-9.
59. Westerhuis JA, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, van Velzen EJJ, et al. 2008. Assessment of PLS-DA cross validation. Metabolomics 4:81-9.
60. Whitfield Aslund ML, McShane H, Simpson MJ, Simpson AJ, Whalen JK, Hendershot WH, et al. 2012. Earthworm sublethal responses to titanium dioxide nanomaterial in soil detected by 1H NMR metabolomics. Environ Sci Technol 46:1111-18.
61. Wiesner MR, Lowry GV, Alvarez P, Dionysiou D, Biswas P. 2006. Assessing the risks of manufactured nanomaterials. Environ Sci Technol 40:4336-45.
62. Wolkow CA, Kimura KD, Lee MS, Ruvkun G. 2000. Regulation of C. elegans life-span by insulin-like signalling in the nervous system. Science 290:147-50.
63. Xia J, Mandal R, Sinelnikov I, Broadhurst D, Wishart DS. 2012. Metaboanalyst 2.0. A comprehensive server for metabolomic data analysis. Nucl Acids Res 40:127-33.
64. Xia J, Wishart DS. 2010. MetPa: a web based metabolomics tool for pathway analysis and visualization. Bioinformatics 26:2342-4.
65. Xuan J, Pan G, Qiu Y, Yang L, Su M, Chen J, et al. 2011. Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res 10:5433-43.
66. 2-NPs toxicity formation at predicted environmental relevant concentrations by Mn-SODs proteins. PLoS One 7:e44688.
67. Zhong Z, Wheeler MD, Li X, Froh M, Schemmer P, Yin M, et al. 2003. L-glycine: a novel anti-inflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Car 6:229-40.